Ramachandran A, Ma RCW, Snehalatha C
Semaglutide is not currently approved for the treatment of type 1 diabetes, and its safety and efficacy in this population have not been established
Possible Side Effects: Nausea, constipation, and stomach discomfort are commonespecially in the early weeks
The effects of semaglutide on the digestive system raise important questions about its potential impact on gastrointestinal health, particularly colonoscopies
Recent real-world research, including studies presented at the European Congress on Obesity, suggests that a slow taper off Wegovy combined with behavioral coaching can help maintain weight loss after medication cessation
SHIRATAMA intravenous therapy, widely offered at aesthetic clinics, is recognized as a method of administering glutathione, a specialized compound utilized in medical institutions